PARP1 and neoplasm: The strategies to overcome the drug resistance of PARP inhibitors mainly include: combined chemotherapy, targeting the vulnerabilities related to drug resistance of PARP inhibitors, inhibiting genomic instability, and delaying the development of drug resistance by increasing the anti-tumor effect of PARP inhibitors.